Valitor

📍 Berkeley, United States🗓 Founded 2010👥 14 employees💰 Last funded Jun 2019
Biotechnology Research🌐 valitorbio.com
Website LinkedIn
Valitor, Inc. is a biotechnology company founded to develop advanced, protein-based drugs. Using our core technology, we can modify existing biological therapies to achieve substantial control over their pharmacological properties. Our mission is to develop a new generation of biologic therapies that will reduce the costs associated with effective treatment of these diseases. We also aim to improve the patients’ quality of life by reducing the required frequency of therapeutic administration. We have initiated a pipeline of drug products that will be used to treat a variety of diseases currently imposing a significant financial burden on the nation’s healthcare system. Valitor is currently hiring! Visit: http://www.valitorbio.com/careers.html for more details.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Valitor?
Valitor has 1 investors on record on gritt.io and 1 late-stage investors.
When did Valitor last raise funding?
The most recent investment in Valitor recorded on gritt.io was in June 2019.
When was Valitor founded?
Valitor was founded in 2010.
What industry is Valitor in?
Valitor operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Valitor based?
Valitor is headquartered in Berkeley, United States.